|Last Price||Today's Change||52-Week Range||Trading Volume|
|29.45||0.07 (+0.24%)||27.86 - 32.96||1.7 million (Above Avg)|
Market data as of 9:48AM 08/29/14. Quotes are delayed by at least 15 min.
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease
08/28/2014 1:15 PM ET